The demise of this company was the purchase of Synageva and the bloated price they paid. They never recovered. Also the failed sales projections on their drugs.
They've been incorrect on all profit projections and their company value has been cut in half.
That being said, the stock price should be too. This stock price should be more in line with $60.00 per share.
Look at their layoffs. They are dumping people left and right. They received a huge tax break from the governor for staying in Connecticut if they create jobs, but that's not happening.
And you'll see more layoffs to come. I'd like to know how they're not reneging on the governor's agreement of creating more jobs.
You must own stock in this and now underwater.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM